At <a href='https://www.linkedin.com/feed/hashtag/?keywords=APHRS2024&highlightedUp…; target='_blank'>#APHRS2024</a>, the CEASE-AF 24-month results were presented. The data demonstrated that Hybrid ablation with left atrial appendage exclusion is effective over the long term, with a ~33% absolute improvement in freedom from atrial arrhythmias* after 24 months of follow-up in patients with long-standing persistent Afib.**​
​
Learn more about the CEASE AF Trial data: <a href="https://okt.to/cKo4mY&quot; target="_blank">https://okt.to/cKo4mY</a&gt;
​
​
*Freedom from atrial arrhythmias (atrial fibrillation, atrial flutter, atrial tachycardia) off anti-arrhythmic drugs (AADs) except previously failed AADs at doses not exceeding those previously failed​​
**Persistent atrial fibrillation with enlarged left atrium and longstanding persistent Afib​​